美国农村与城市医院心力衰竭住院患者医疗质量与结局比较:GWTG-HF注册研究
该回顾性队列研究分析2014至2021年GWTG-HF注册中569家中心的774 419例心衰住院患者,比较农村与城市医院的医疗质量和结局。农村医院患者出院时接受心脏再同步治疗、ACEI/ARB及ARNI的比例较低,住院时间≥4天的比例较低,但住院死亡率和30天出院后结局与城市医院相似。
要点
- 农村医院心衰患者出院时接受CRT、ACEI/ARB和ARNI的比例显著低于城市医院。
- 农村与城市医院住院死亡率及30天再入院和死亡结局无显著差异。
- 农村医院患者住院时间≥4天的比例较低。
核心结论
- 农村医院心衰住院患者出院时部分指南推荐治疗的使用率较低且住院时间较短,但住院死亡率和30天出院后结局与城市医院相似。
研究设计与样本
- 回顾性队列研究,分析2014年1月1日至2021年9月30日GWTG-HF注册中569家中心的774 419例心衰住院患者,其中农村医院49家(19 832例,2.6%),城市医院520家(754 587例,97.4%)。
- 出院后结局在161 996例链接Medicare索赔数据的患者子集中评估。
主要发现
- 农村医院患者较城市医院患者年龄更大(中位74岁 vs 73岁,标准化差10.63)且非西班牙裔白人比例更高(73.5% vs 66.1%,标准化差34.47)。
- 调整后农村医院患者出院时接受心脏再同步治疗(aRD -13.5%;aOR 0.44;95%CI 0.22-0.92)、ACEI或ARB(aRD -3.7%;aOR 0.71;95%CI 0.53-0.96)及ARNI(aRD -5.0%;aOR 0.68;95%CI 0.47-0.98)的可能性较低。
- 住院死亡率农村医院为2.3%(460/19 832),城市医院为2.7%(20 529/754 587),aOR 0.86(95%CI 0.70-1.07)。
- 农村医院患者住院时间≥4天的可能性较低(aOR 0.75;95%CI 0.67-0.85)。
- Medicare受益人中,农村与城市医院30天心衰再入院(aHR 1.03;95%CI 0.90-1.19)、全因再入院(aHR 0.97;95%CI 0.91-1.04)和全因死亡(aHR 1.05;95%CI 0.91-1.21)无显著差异。
关键数值与推荐
- 农村医院患者出院时CRT使用调整后风险差为-13.5%(aOR 0.44;95%CI 0.22-0.92)。
- 农村医院患者出院时ACEI/ARB使用调整后风险差为-3.7%(aOR 0.71;95%CI 0.53-0.96)。
- 农村医院患者出院时ARNI使用调整后风险差为-5.0%(aOR 0.68;95%CI 0.47-0.98)。
- 住院时间≥4天的aOR为0.75(95%CI 0.67-0.85)。
- 30天结局的aHR:心衰再入院1.03(95%CI 0.90-1.19),全因再入院0.97(95%CI 0.91-1.04),全因死亡1.05(95%CI 0.91-1.21)。
临床怎么用
- 农村医院应关注提高指南推荐的心衰出院治疗(CRT、ACEI/ARB、ARNI)的使用率。
- 农村与城市医院住院死亡率和30天结局相似,提示短期结局并非农村医院的主要短板。
- 农村医院住院时间较短,需结合患者情况评估出院后随访衔接。
局限性
- 出院后结局仅在链接Medicare索赔数据的子集中评估,可能影响代表性。
- 研究为回顾性观察性设计,无法排除未测量混杂因素。
- 农村医院样本量相对较小(49家,19 832例)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Prior studies have suggested patients with heart failure (HF) from rural areas have worse clinical outcomes. Contemporary differences between rural and urban hospitals in quality of care and clinical outcomes for patients hospitalized for HF remain poorly understood. OBJECTIVE: To assess quality of care and clinical outcomes for US patients hospitalized for HF at rural vs urban hospitals. DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study analyzed 774 419 patients hospitalized for HF across 569 sites in the Get With The Guidelines-Heart Failure (GWTG-HF) registry between January 1, 2014, and September 30, 2021. Postdischarge outcomes were assessed in a subset of 161 996 patients linked to Medicare claims. Data were analyzed from August 2022 to January 2023. MAIN OUTCOMES AND MEASURES: GWTG-HF quality measures, in-hospital mortality, length of stay, and 30-day mortality and readmission outcomes. RESULTS: This study included 19 832 patients (2.6%) and 754 587 patients (97.4%) hospitalized at 49 rural hospitals (8.6%) and 520 urban hospitals (91.4%), respectively. Of 774 419 included patients, 366 161 (47.3%) were female, and the median (IQR) age was 73 (62-83) years. Compared with patients at urban hospitals, patients at rural hospitals were older (median [IQR] age, 74 [64-84] years vs 73 [61-83] years; standardized difference, 10.63) and more likely to be non-Hispanic White (14 572 [73.5%] vs 498 950 [66.1%]; standardized difference, 34.47). In adjusted models, patients at rural hospitals were less likely to be prescribed cardiac resynchronization therapy (adjusted risk difference [aRD], -13.5%; adjusted odds ratio [aOR], 0.44; 95% CI, 0.22-0.92), angiotensin-converting enzyme inhibitor or angiotensin receptor blocker (aRD, -3.7%; aOR, 0.71; 95% CI, 0.53-0.96), and an angiotensin receptor-neprilysin inhibitor (aRD, -5.0%; aOR, 0.68; 95% CI, 0.47-0.98) at discharge. In-hospital mortality was similar between rural and urban hospitals (460 of 19 832 [2.3%] vs 20 529 of 754 587 [2.7%]; aOR, 0.86; 95% CI, 0.70-1.07). Patients at rural hospitals were less likely to have a length of stay of 4 or more days (aOR, 0.75; 95% CI, 0.67-0.85). Among Medicare beneficiaries, there were no significant differences between rural and urban hospitals in 30-day HF readmission (adjusted hazard ratio [aHR], 1.03; 95% CI, 0.90-1.19), all-cause readmission (aHR, 0.97; 95% CI, 0.91-1.04), and all-cause mortality (aHR, 1.05; 95% CI, 0.91-1.21). CONCLUSIONS AND RELEVANCE: In this large contemporary cohort of US patients hospitalized for HF, care at rural hospitals was independently associated with lower use of some guideline-recommended therapies at discharge and shorter length of stay. In-hospital mortality and 30-day postdischarge outcomes were similar at rural and urban hospitals.
引用
- Pierce, Ikeaba, Peters, et al. Quality of Care and Outcomes Among Patients Hospitalized for Heart Failure in Rural vs Urban US Hospitals: The Get With The Guidelines-Heart Failure Registry. JAMA Cardiol. 2023. PMID: 36806447. doi:10.1001/jamacardio.2023.0241
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。